LEX Diagnostics wins FDA clearance for ultra-fast PCR platform to accelerate point-of-care testing
LEX Diagnostics has secured US Food and Drug Administration 510(k) clearance and CLIA waived status for its VELO molecular diagnostics system, an ultra-rapid point-of-care platform capable of delivering highly sensitive PCR results for major respiratory pathogens directly from a swab sample in under ten minutes.
<br />
PCR Platform | 17/02/2026 | By Darshana | 243
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy